CRH MEDICAL CORPORATION (TSE:CRH) Files An 8-K Regulation FD Disclosure
ITEM 7.01 REGULATION FD DISCLOSURE
On November 6, 2019, CRH Medical Corporation issued a press release announcing that it has received approval from the Toronto Stock Exchange of its Notice of Intention to renew its existing Normal Course Issuer Bid. A copy of the press release is being furnished herewith as Exhibit 99.1.
The information provided under this Form 8-K (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.
ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS
(d) Exhibits
| 99.1 | Press Release issued by CRH Medical Corporation on November 6, 2019 |
CRH Medical Corp Exhibit
EX-99.1 2 ex991.htm NEWS RELEASE DATED NOVEMBER 6,…
To view the full exhibit click here
